Patient Focus: Sodium-Glucose Cotransporter-2 Inhibitor Rates for Patients with Heart Failure in the Veterans Affairs Health System: We Need to Move the Needle! An Explanation of Uptake of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized due to Heart Failure: Insights from the Veterans Affairs Healthcare System
-
Published:2024-01
Issue:
Volume:
Page:
-
ISSN:1071-9164
-
Container-title:Journal of Cardiac Failure
-
language:en
-
Short-container-title:Journal of Cardiac Failure
Author:
HENDREN NICHOLAS S.,
THIBODEAU JENNIFER T.ORCID
Reference4 articles.
1. Empagliflozin in heart failure with a preserved ejection fraction;Anker;N Engl J Med,2021
2. Dapagliflozin in patients with heart failure and reduced ejection fraction;McMurray;N Engl J Med,2019
3. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Heidenreich;Circulation,2022
4. Voluntary reporting of Guideline-Directed Medical Therapy use rates in the public domain: a challenge to the heart failure community;Thibodeau;J Card Fail,2023